US Patent 10544223 Combination therapy with an anti-axl antibody-drug conjugate
All edits
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 11 Dec, 2023
Golden AI
Edits made to:
Article (+285 characters)
Article
Patent abstract
The present disclosure relates to combination therapies for the treatment of pathological conditions, such as cancer. In particular, the present disclosure relates to combination therapies comprising treatment with an Antibody Drug Conjugate (ADC) and a secondary agent.
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Francesca Zammarchi0
Jens Wuerthner0
John Hartley0
Patricius Hendrikus Cornelis Van Berkel0
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
105442230
Date of Patent
January 28, 2020
0Patent Application Number
161978910
Date Filed
November 21, 2018
0Patent Primary Examiner
Edits on 1 Feb, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 10544223 Combination therapy with an anti-axl antibody-drug conjugate
Infobox
Is a
Patent jurisdiction
Patent number
10544223
Date of patent
January 28, 2020
Patent application number
16197891
Date Filed
November 21, 2018
Patent primary examiner
Find more entities like US Patent 10544223 Combination therapy with an anti-axl antibody-drug conjugate
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.